Sera Prognostics (SERA) EBITDA (2020 - 2026)
Sera Prognostics' (SERA) quarterly EBITDA came in at -$9.4 million in Q1 2026, down 1.19% YoY from -$9.5 million in Q1 2025, and down 4.53% on a QoQ basis from -$9.0 million in Q4 2025.
Sera Prognostics (SERA) EBITDA (2020 - 2026) Analysis & Trends
Sera Prognostics (SERA) has 7 years of EBITDA data on file, last reported at -$9.4 million in Q1 2026.
- Quarterly EBITDA fell 1.19% year-over-year to -$9.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$36.6 million (changed 0.47% YoY) and the FY2025 annual result came in at -$36.5 million, changed 0.36% from the prior year.
- EBITDA declined to -$9.4 million in Q1 2026, from -$9.0 million in the prior quarter.
- In the past five years, EBITDA ranged from a high of -$8.2 million in Q3 2023 to a low of -$12.3 million in Q1 2022.
- A 5-year average of -$9.9 million and a median of -$9.3 million in 2025 frame the typical range for EBITDA.
- Annual changes were most pronounced in 2022 — EBITDA plunged 104.15% — and 2023, when it grew 26.85%.
- Tracing SERA's EBITDA over 5 years: stood at -$10.4 million in 2022, then climbed by 15.07% to -$8.8 million in 2023, then fell by 6.5% to -$9.4 million in 2024, then climbed by 4.98% to -$9.0 million in 2025, then decreased by 4.53% to -$9.4 million in 2026.
- The last three EBITDA figures came in at -$9.4 million (Q1 2026), -$9.0 million (Q4 2025), and -$9.0 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.61 Bn | 194.01 Bn | 7.27 Bn | 1.69 Bn |
| 2 | Stryker | 127.81 Bn | 124.34 Bn | 4.50 Bn | 1.66 Bn |
| 3 | Medtronic | 119.04 Bn | 109.82 Bn | 6.41 Bn | 1.87 Bn |
| 4 | Boston Scientific | 73.68 Bn | 73.14 Bn | 3.85 Bn | 1.18 Bn |
| 5 | Edwards Lifesciences | 51.96 Bn | 47.71 Bn | 1.35 Bn | 513.20 Mn |
| 6 | Dexcom | 34.36 Bn | 32.41 Bn | 830.00 Mn | 318.30 Mn |
| 7 | GE HealthCare Technologies | 33.83 Bn | 31.72 Bn | 2.18 Bn | 739.00 Mn |
| 8 | Koninklijke Philips | 26.36 Bn | 23.04 Bn | 4.55 Bn | 989.17 Mn |
| 9 | Steris | 23.06 Bn | 22.58 Bn | 684.20 Mn | 285.80 Mn |
| 10 | Sera Prognostics | 103.23 Mn | 103.23 Mn | -20,000.00 | -10.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -10.00 Mn |
| Mar 31, 2026 | -9.36 Mn |
| Dec 31, 2025 | -8.95 Mn |
| Sep 30, 2025 | -8.98 Mn |
| Jun 30, 2025 | -9.32 Mn |
| Mar 31, 2025 | -9.25 Mn |
| Dec 31, 2024 | -9.42 Mn |
| Sep 30, 2024 | -8.86 Mn |
| Jun 30, 2024 | -9.25 Mn |
| Mar 31, 2024 | -9.10 Mn |
| Dec 31, 2023 | -8.85 Mn |
| Sep 30, 2023 | -8.18 Mn |
| Jun 30, 2023 | -11.46 Mn |
| Mar 31, 2023 | -11.33 Mn |
| Dec 31, 2022 | -10.42 Mn |
| Sep 30, 2022 | -11.19 Mn |
| Jun 30, 2022 | -11.75 Mn |
| Mar 31, 2022 | -12.30 Mn |
| Dec 31, 2021 | -12.55 Mn |
| Sep 30, 2021 | -9.44 Mn |